##################################################################################
# Document Properties
##################################################################################
SET DOCUMENT Name = "Zhang_et.al_2020.bel"
SET DOCUMENT Authors = "Geena Mariya Jose"
SET DOCUMENT ContactInfo = "geena.mariya.jose@causalitybiomodels.com"
SET DOCUMENT Description = "COVID Knowledge Curation project"

SET DOCUMENT Licenses = "Private Ownership to Fraunhofer Institute SCAI"
SET DOCUMENT Copyright = "Copyright Â© 2020 Fraunhofer Institute SCAI, All rights reserved"
SET DOCUMENT Version = "2.0.0"

##################################################################################
# NAMESPACES Section
##################################################################################

# DEFINE NAMESPACE CONSO          AS URL "https://raw.githubusercontent.com/pharmacome/conso/3c93a65dc48e6786fe29ae55aa36cf9a902fe8c6/export/conso-names.belns"
# DEFINE NAMESPACE ECCODE         AS URL "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/ec-code.belns"
# DEFINE NAMESPACE EFO            AS URL "https://raw.githubusercontent.com/pharmacome/conso/5d2c2ea6f7112421cc8089a3f021a75ab60bb373/external/efo-names.belns"
# DEFINE NAMESPACE FB             AS URL "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/fb-names.belns"
# DEFINE NAMESPACE MIRBASE        AS URL "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/mirbase-names.belns"

# DEFINE NAMESPACE ADO AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/alzheimer-disease-ontology/alzheimer-disease-ontology-1.0.2.belns"
# DEFINE NAMESPACE BRCO AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/brain-region-ontology/brain-region-ontology-1.0.0.belns"
# DEFINE NAMESPACE NIFT AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/nift/NIFT.belns"

DEFINE NAMESPACE HGNC AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/hgnc/hgnc-20190708.belns"
# DEFINE NAMESPACE MGI AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/mgi-mouse-genes/mgi-mouse-genes-20190128.belns"
# DEFINE NAMESPACE RGD AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/rgd-rat-genes/rgd-rat-genes-20190128.belns"
# DEFINE NAMESPACE GFAM AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/hgnc-gene-families/hgnc-genefamily-names-20181221.belns"
# DEFINE NAMESPACE SCOMP AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/selventa-named-complexes/selventa-named-complexes-20190128.belns"
# DEFINE NAMESPACE SFAM AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/selventa-protein-families/selventa-protein-families-20190128.belns"
# DEFINE NAMESPACE HP AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/hp/hp-20190130.belns"
DEFINE NAMESPACE CHEBI AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/chebi/chebi-20190708.belns"
DEFINE NAMESPACE TAX AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/ncbi-taxonomy/ncbi-taxonomy-20200322.belns"
# DEFINE NAMESPACE DRUGBANK AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/drugbank/drugbank-20180906.belns"
# DEFINE NAMESPACE INTERPRO AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/interpro/interpro-names-20181021.belns"
# DEFINE NAMESPACE PFAM AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/pfam/pfam-names-20181024.belns"
DEFINE NAMESPACE DO AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/disease-ontology/disease-ontology-20200407.belns"
DEFINE NAMESPACE GO AS URL 	"https://arty.scai.fraunhofer.de/artifactory/bel/namespace/go/go-20180109.belns"
DEFINE NAMESPACE GOBP AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/go-biological-process/go-biological-process-20190128.belns"
DEFINE NAMESPACE GOCC AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/go-cellular-component/go-cellular-component-20190128.belns"

DEFINE NAMESPACE MESH AS URL 	"https://arty.scai.fraunhofer.de/artifactory/bel/namespace/mesh/mesh-names-20181007.belns"

# DEFINE NAMESPACE MESHC AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/mesh-chemicals/mesh-chemicals-20190128.belns"
# DEFINE NAMESPACE MESHD AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/mesh-diseases/mesh-diseases-20190128.belns"
# DEFINE NAMESPACE MESHPP AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/mesh-processes/mesh-processes-20190128.belns"
# DEFINE NAMESPACE MESHA AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/mesh-anatomy/mesh-anatomy-20190128.belns"
# DEFINE NAMESPACE MESHCS AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/mesh-cellular-structures/mesh-cellular-structures-20190128.belns"
# DEFINE NAMESPACE NCBITAXON AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/ncbi-taxonomy/ncbi-taxonomy-20200322.belns"
# DEFINE NAMESPACE FPLX           AS URL "https://raw.githubusercontent.com/sorgerlab/famplex/d9ec0526c20795146a9a6aef17496efe1a36cac6/export/famplex.belns"

DEFINE NAMESPACE COVID AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/ncbi-covid19/ncbi-covid19-20200326.belns"
DEFINE NAMESPACE NCBIGENE AS PATTERN "^\d+$"
# DEFINE NAMESPACE TAXONOMY       AS PATTERN "^\d+$"
DEFINE NAMESPACE UNIPROT AS PATTERN "^([A-N,R-Z][0-9]([A-Z][A-Z, 0-9][A-Z, 0-9][0-9]){1,2})|([O,P,Q][0-9][A-Z, 0-9][A-Z, 0-9][A-Z, 0-9][0-9])(\.\d+)?$"
# DEFINE NAMESPACE PUBCHEM AS PATTERN "^\d+$"
# DEFINE NAMESPACE dbSNP AS PATTERN "rs[0-9]+"

##################################################################################
# ANNOTATIONS Section
##################################################################################

# DEFINE ANNOTATION Anatomy AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/anatomy/anatomy-20190128.belanno"
DEFINE ANNOTATION CellLine AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-line/cell-line-20170511.belanno"
# DEFINE ANNOTATION Cell AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell/cell-20190128.belanno"
# DEFINE ANNOTATION Disease AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/disease/disease-20190128.belanno"
DEFINE ANNOTATION MeSHAnatomy AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20190128.belanno"
# DEFINE ANNOTATION MeSHDisease AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20190128.belanno"
DEFINE ANNOTATION Species AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/species-taxonomy-id/species-taxonomy-id-20170511.belanno"
# DEFINE ANNOTATION TextLocation AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/text-location/text-location-1.0.1.belanno"
# DEFINE ANNOTATION BioAssay AS PATTERN ".*"
# DEFINE ANNOTATION CellStructure AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-structure/cell-structure-20170511.belanno"
# DEFINE ANNOTATION Confidence    AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno"
# DEFINE ANNOTATION Gender        AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/gender/gender-1.0.0.belanno"

DEFINE ANNOTATION Custom_CellLine AS LIST {"HEK293T"}
DEFINE ANNOTATION CellLine_Infection_Type AS LIST {"HIV-luc/2019-nCoV-S", "HIV-luc/SARS-CoV-S", "Severe acute respiratory syndrome coronavirus 2"} 
DEFINE ANNOTATION Assay AS LIST {"Luciferase assay"}

# Document Annotations #
DEFINE ANNOTATION PublicationType AS LIST {"Research"}
DEFINE ANNOTATION PublicationStatus AS LIST {"Preprint"}
DEFINE ANNOTATION Section AS LIST {"Results"}

##################################################################################
# Statements #
##################################################################################

SET Citation = {"DOI", "https://doi.org/10.1101/2020.02.05.935387 "}
SET PublicationType = "Research"
SET PublicationStatus = "Preprint"
SET Section = "Results"

SET Evidence = "After alignment, we found that the cleavage site of cathepsin L is well conserved between the SARS-CoV and 2019-nCoV S protein (Figure 1A), suggesting that cathepsin L could participant in the 2019-nCoV entry and fusion26,31,32."
SET Species = "9606"
act(p(HGNC:CTSL)) -> p(COVID:S, frag("?"))
p(COVID:S, frag("?")) -> bp(GO:"viral entry into host cell")
p(COVID:S, frag("?")) -> bp(GO:"fusion of virus membrane with host outer membrane")

SET Evidence = "Accordingly, we infected the cells with SARS-CoV-, or 2019- nCoV -S- pseudotyped HIV-1 viruses after siRNA-mediated knockdown of the expression of cathepsin L and TMPRSS2 and found that both cathepsin L and TMPRSS2 depletion impaired the cell entry of pseudoviruses (Figure 1C), indicating that both cathepsin L and TMPRSS2 are required for 2019- nCoV cell entry."
SET Custom_CellLine = "HEK293T"
SET CellLine_Infection_Type = {"HIV-luc/2019-nCoV-S", "HIV-luc/SARS-CoV-S"}
SET Assay = "Luciferase assay" 
act(p(HGNC:CTSL)) -> bp(GO:"viral entry into host cell")
act(p(HGNC:TMPRSS2)) -> bp(GO:"viral entry into host cell")
UNSET Custom_CellLine 
UNSET CellLine_Infection_Type 

SET Evidence = "Here, we identified that teicoplanin acted specifically as a 2019-nCoV entry inhibitor in a dose-dependent manner (Figure 2B)."
SET CellLine_Infection_Type = "HIV-luc/2019-nCoV-S"
SET CellLine = "A549 cell"
a(CHEBI:teicoplanin) -| bp(GO:"viral entry into host cell")
bp(GO:"viral entry into host cell") -- a(TAX:"Severe acute respiratory syndrome coronavirus 2")
UNSET CellLine 
UNSET CellLine_Infection_Type 

SET Evidence = "The data showed that teicoplanin also effectively repressed virus entrance into HEK293T cells (Figure. 3A), and Huh7 cells (Figure 3B)."
SET Custom_CellLine = "HEK293T"
SET CellLine = "Huh7 cell"
SET CellLine_Infection_Type = "Severe acute respiratory syndrome coronavirus 2"
a(CHEBI:teicoplanin) -| bp(GO:"viral entry into host cell")
bp(GO:"viral entry into host cell") -- a(TAX:"Severe acute respiratory syndrome coronavirus 2")
UNSET Custom_CellLine 
UNSET CellLine 
UNSET CellLine_Infection_Type 

SET Evidence = "As we have previously demonstrated that several glycopeptide antibiotics, including teicoplanin and dalbavancin, exhibited specific inhibitory effects on cathepsin L, we therefore hypothesized that teicoplanin and its homologs could also inhibit the entry of 2019-nCoV."
a(CHEBI:teicoplanin) -| p(HGNC:CTSL)
a(CHEBI:dalbavancin) -| p(HGNC:CTSL)
a(CHEBI:teicoplanin) -| bp(GO:"viral entry into host cell")
a(CHEBI:dalbavancin) -| bp(GO:"viral entry into host cell")

SET Evidence = "The data illustrated that the dalbavancin also repressed the entry of 2019-nCoV in a dose-dependent manner (Figure 3C)."
SET CellLine = "A549 cell"
SET CellLine_Infection_Type = "Severe acute respiratory syndrome coronavirus 2"
a(CHEBI:dalbavancin) -| bp(GO:"viral entry into host cell")
UNSET CellLine 
UNSET CellLine_Infection_Type
UNSET Assay
UNSET Species
UNSET PublicationType
UNSET PublicationStatus
UNSET Section

##################################################################################

# SET DOCUMENT Authors = "Yojana Gadiya"

SET Evidence = "The infection of SARS virus is initiated by the attachment of S protein to the receptor ACE2 [19], followed by cleavage with host cell protease TMPRSS2 [20-22]. The viruses are then transported through the early and late endosomes, subsequently endo/lysosomes, during which host protein extracellular proteases including cathepsin L mediates the further cleavage of S protein in endocytic vesicles [23-26]. The activated S protein will then activate the fusion between viral and cell membranes and release the genome of SARS-CoV into cytoplasm."
complex(p(UNIPROT:P0DTC2),p(HGNC:ACE2)) -> composite(complex(p(UNIPROT:P0DTC2),p(HGNC:ACE2)),p(HGNC:TMPRSS2))
composite(complex(p(UNIPROT:P0DTC2),p(HGNC:ACE2)),p(HGNC:TMPRSS2)) -> p(UNIPROT:P0DTC2,frag("?"))
p(UNIPROT:P0DTC2,frag("?")) -> bp(GOBP:"endosome membrane permeabilization involved in viral entry into host cell")
bp(GOBP:"endosome membrane permeabilization involved in viral entry into host cell") -> bp(GOBP:"endosome lysis involved in viral entry into host cell")
SET MeSHAnatomy = "Lysosomes"
bp(GOBP:"endosome lysis involved in viral entry into host cell") -> path(DO:"COVID-19")
path(DO:"COVID-19") -> act(p(HGNC:CTSL))
UNSET MeSHAnatomy
#second fragmentation
act(p(HGNC:CTSL)) -> p(UNIPROT:P0DTC2,frag("?"))
p(UNIPROT:P0DTC2,frag("?")) -> act(p(UNIPROT:P0DTC2))
act(p(UNIPROT:P0DTC2)) -> bp(GOBP:"membrane fusion involved in viral entry into host cell")
SET MeSHAnatomy = "Cytoplasm"
bp(GOBP:"membrane fusion involved in viral entry into host cell") -> path(MESH:"Genome, Viral")
UNSET MeSHAnatomy

SET Evidence = "Accordingly, we infected the cells with SARS-CoV-, or 2019-nCoV-S-pseudotyped HIV-1 viruses after siRNA-mediated knockdown of the expression of cathepsin L and TMPRSS2 and found that both cathepsin L and TMPRSS2 depletion impaired the cell entry of pseudoviruses (Figure 1C), indicating that both cathepsin L and TMPRSS2 are required for 2019-nCoV cell entry."
p(HGNC:CTSL) pos bp(GOBP:"viral entry into host cell")
p(HGNC:TMPRSS2) pos bp(GOBP:"viral entry into host cell")

SET Evidence  = "Here, we identified that teicoplanin acted specifically as a 2019-nCoV entry inhibitor in a dose-dependent manner (Figure 2B)."
a(CHEBI:teicoplanin) -| p(HGNC:CTSL)
a(CHEBI:teicoplanin) -| bp(GOBP:"viral entry into host cell")

SET Evidence = "The data showed that teicoplanin also effectively repressed virus entrance into HEK293T cells (Figure. 3A), and Huh7 cells (Figure 3B)."
SET CellLine = {"HEK293T","Huh7 cell"}
a(CHEBI:teicoplanin) -| bp(GOBP:"viral entry into host cell")
UNSET CellLine

SET Evidence = "The data illustrated that the dalbavancin also repressed the entry of 2019-nCoV in a dose-dependent manner (Figure 3C)."
a(CHEBI:dalbavancin) -| p(HGNC:CTSL)
a(CHEBI:dalbavancin) -| bp(GOBP:"viral entry into host cell")
